Oregon State University research pushes closer to new therapy for pancreatic cancer

PORTLAND, Ore. – Research by Oregon State University has uncovered a potential new therapy for pancreatic cancer, whose survival rate is among the lowest of all malignancies.

Oregon State donors make more than 6,300 gifts totaling $1.55 million in 24 hours

Supporters of Oregon State University came together on April 27, 2022, to raise $1.55 million through more than 6,300 gifts during the university’s annual day of giving and engagement.

For cancer patients on immunotherapy, harmful gut bacteria might matter more than helpful ones

CORVALLIS, Ore. – Melanoma patients receiving therapy that helps their immune system kill cancer cells respond to treatment differently depending on the types of microbes in their gut, and new research suggests the microorganisms hindering therapy have more influence than the beneficial ones.

Oregon State fall enrollment sets record, driven by in-person and online offerings

Oregon State University’s fall 2021 enrollment again has reached record levels, with strong demand for in-person and online classes, a continued rise in students of color and surging interest in an OSU education from out-of-state students.

Oregon State receives $10 million grant to study hemp market in western U.S.

Oregon State University’s Global Hemp Innovation Center has been awarded a $10 million grant from the U.S. Department of Agriculture to define economic opportunities for hemp in the western United States.

Oregon State University research enterprise continues upward trend

CORVALLIS, Ore. – Research funding at Oregon State University has topped $380 million for the fifth straight fiscal year, and research expenditures by the university, a key measure of research output, rose despite the pandemic for the seventh consecutive year, increasing by 5%.

Efforts to reduce opioid prescriptions may be hindering end-of-life pain management

PORTLAND, Ore. – Policies designed to prevent the misuse of opioids may have the unintended side effect of limiting access to the pain-relieving drugs by terminally ill patients nearing the end of their life, new research led by the Oregon State University College of Pharmacy suggests.

Melanoma patients respond to immunotherapy after changes to gut microbiome

CORVALLIS, Ore. – Statistical modeling developed by Oregon State University researchers has confirmed that changes to melanoma patients’ gut microbiome led them to respond to a type of treatment capable of providing long-term benefit.

Research shows a few beneficial organisms could play key role in treating type 2 diabetes

Researchers at Oregon State University have found that a few organisms in the gut microbiome play a key role in type 2 diabetes, opening the door to possible probiotic treatments for a serious metabolic disease affecting roughly one in 10 Americans.

OSU to pilot smartphone-based COVID-19 exposure notifications system

Oregon State University is teaming up with the Oregon Health Authority to test a smartphone-based system that notifies users about possible exposure to COVID-19.

Pages